Find a Collaborator
A/Prof Alfredo FRANCO-OBREGON
Cancer Stem Cells
I approach tissue engineering, regeneration and development from a biophysical perspective, as an alternative to conventional pharmacological interventions. I am particularly interested in how mechanical and electromagnetic forces drive development and can be used to control disease. My areas of interest are skeletal muscle development, cancer and stem cell biology.
Prof KOH Liang Piu
Cancer Stem Cells
Research focuses mainly on clinical Haematopoietic Stem Cell Transplantation in particular Nonmyeloablative Stem Cell Transplant, haploidentical donor transplant, Umbilical Cord Blood Transplantation in Haematological Malignancies. He also the leading primary investigators on clinical trials on Infectious Complications in Haematological / Haematopoietic Stem Cell Transplantation Recipients, studies on Graft vs. Host Disease prevention and treatment.
Dr LIM Gkeok Stzuan, Diana
Cancer Stem Cells
Dr Diana Lim is a senior consultant pathologist and director of the Diagnostic Molecular Oncology Centre (DMOC) in National University Hospital. Her subspecialty and research interest lies in gynaecologic and molecular pathology.
Dr ONG Sek Tong, Derrick
Cancer Stem Cells
Research focus is on identifying new glioblastoma dependency in the area of cancer epigenetics as we try to develop innovative and durable GBM treatment modalities. We are also interested to understand the mechanisms that regulate non-cancerous brain stem cell function, in order to discover new ways to retard/reverse brain aging.
Dr ONG Sek Tong, Derrick
Cancer Stem Cells
Research focus is on identifying new glioblastoma dependency in the area of cancer epigenetics as we try to develop innovative and durable GBM treatment modalities. We are also interested to understand the mechanisms that regulate non-cancerous brain stem cell function, in order to discover new ways to retard/reverse brain aging.
Prof Toshio SUDA
Cancer Stem Cells
Research focus is based on the hypothesis that the bone marrow (BM) microenvironment known as the stem cells niche is essential for the maintenance of hematopoietic stem cells (HSC) quiescence in cell cycle and regulates the fate of HSCs. We aim for the regulation of stem cells by niche as niche therapy. We will dissect the niche as a functional unit of stem cell regulation and aim to expand stem cells using ex vivo artificial niches and improve the method for BM transplantation.
Prof Toshio SUDA
Cancer Stem Cells
Research focus is based on the hypothesis that the bone marrow (BM) microenvironment known as the stem cells niche is essential for the maintenance of hematopoietic stem cells (HSC) quiescence in cell cycle and regulates the fate of HSCs. We aim for the regulation of stem cells by niche as niche therapy. We will dissect the niche as a functional unit of stem cell regulation and aim to expand stem cells using ex vivo artificial niches and improve the method for BM transplantation.
A / Prof KOH Liang Piu
Cancer Stem Cells
Research focuses mainly on clinical Haematopoietic Stem Cell Transplantation in particular Nonmyeloablative Stem Cell Transplant, haploidentical donor transplant, Umbilical Cord Blood Transplantation in Haematological Malignancies. He also the leading primary investigators on clinical trials on Infectious Complications in Haematological / Haematopoietic Stem Cell Transplantation Recipients, studies on Graft vs. Host Disease prevention and treatment.
Prof Toshio SUDA
Cancer Stem Cells
Research focus is based on the hypothesis that the bone marrow (BM) microenvironment known as the stem cells niche is essential for the maintenance of hematopoietic stem cells (HSC) quiescence in cell cycle and regulates the fate of HSCs. We aim for the regulation of stem cells by niche as niche therapy. We will dissect the niche as a functional unit of stem cell regulation and aim to expand stem cells using ex vivo artificial niches and improve the method for BM transplantation.
Secondary Members
Dr TOH Tan Boon
Cancer Stem Cells
Our lab focuses on advancing functional precision and personalized
oncology by developing patient-derived models that accurately reflect the molecular and cellular complexity of human cancers. Additionally, our research investigates the clinically relevant mechanisms of drug resistance in these models to enhance therapeutic
effectiveness.
Prof KOH Liang Piu
Cancer Stem Cells
Research focuses mainly on clinical Haematopoietic Stem Cell Transplantation in particular Nonmyeloablative Stem Cell Transplant, haploidentical donor transplant, Umbilical Cord Blood Transplantation in Haematological Malignancies. He also the leading primary investigators on clinical trials on Infectious Complications in Haematological / Haematopoietic Stem Cell Transplantation Recipients, studies on Graft vs. Host Disease prevention and treatment.
Dr LIM Gkeok Stzuan, Diana
Cancer Stem Cells
Dr Diana Lim is a senior consultant pathologist and director of the Diagnostic Molecular Oncology Centre (DMOC) in National University Hospital. Her subspecialty and research interest lies in gynaecologic and molecular pathology.
